Back Back
Cell No. : Cell Name
RCB2146 : WERI-Rb-1  update : 2021/02/26
CommentHuman cell line derived from retinoblastoma. TKG0601 (Deposited from Tohoku Univ.).
Comment from the depositor
Terms and conditionsThere is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (
Basic information Depositor Obinata, Masuo
Originator McFall R.M. & Sery T.W.
Year of deposit 2005
Original cell TKG0601
Animal _human < Mammals
Genus Homo
Species sapiens
Race Caucasian
Gender Female
Age at sampling 1 year
Tissue eye
Disease name retinoblastoma
Classification cancer
History Cell Resource Center for Biomedical Research, Tohoku University(TKG0601)
Lifespan infinite
Morphology other
deposit info
lot info
Medium Medium List
Culture type Suspension cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method dilution
Culture information Passage ratio 1 : 4 split
SC frequency Subculture : once/week, Medium Renewal : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR(human) OK
Isozyme LD, NP
deposit info
lot info
Reference information Reference 2
User's Publication 14

To topTop
4982  McFall RC, Nagy RM, Nagle BT, McGreevy LM.  Scanning electron microscopic observation of two retinoblastoma cell lines.  Cancer Res  1978  38(9):2827-35  PubMed ID: 679190
4981  McFall RC, Sery TW, Makadon M.  Characterization of a new continuous cell line derived from a human retinoblastoma.  Cancer Res  1977  37(4):1003-10  PubMed ID: 844036

To topTop
User's Publication
13082  Raguraman R, Parameswaran S, Kanwar JR, Vasudevan M, Chitipothu S, Kanwar RK, Krishnakumar S.  Gene expression profiling of tumor stroma interactions in retinoblastoma.  Exp Eye Res  2020    PubMed ID: 32585195
13774  Ravishankar H, Mangani AS, Shankar MB, Joshi M, Devasena T, Parameswaran S, Subramaniam K.  Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site  Histochem Cell Biol  2020  153(2):101-109  PubMed ID: 31781967
12604  Athyala PK, Chitipothu S, Kanwar JR, Krishnakumar S, Narayanan J.  Synthesis of saporin-antibody conjugates for targeting EpCAM positive tumour cells  IET Nanobiotechnol  2019  13(1):90-99  PubMed ID: 30964044
9718  Jayashree B, Srimany A, Jayaraman S, Bhutra A, Janakiraman N, Chitipothu S, Krishnakumar S, Baddireddi LS, Elchuri S, Pradeep T.  Monitoring of changes in lipid profiles during PLK1 knockdown in cancer cells using DESI MS.  Anal Bioanal Chem  2016  408:5623-32  PubMed ID: 27277815
9743  Nalini V, Deepa PR, Raguraman R, Khetan V, Reddy MA, Krishnakumar S.  Targeting HMGA2 in Retinoblastoma Cells in vitro Using the Aptamer Strategy.  Ocul Oncol Pathol  2016  2:262-269  PubMed ID: 27843907
10861    Targeting CD44, ABCG2 and CD133 markers using aptamers: in silico analysis of CD133 extracellular domain 2 and its aptamer  RSC Adv.  2016  6, 32115-32123 
7226  Subramanian N, Kanwar JR, Kanwar RK, Krishnakumar S.  Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.  Nucleic Acid Ther  2015  25:317-22  PubMed ID: 26334953
7342  Venkatesan N, Deepa PR, Khetan V, Krishnakumar S.  Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.  Bioinform Biol Insights  2015  9:89-101  PubMed ID: 25983556
7360  Sangeetha M, Deepa PR, Rishi P, Khetan V, Krishnakumar S.  Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.  J. Cell. Biochem.  2015  116:2676-94  PubMed ID: 25958981
7515  Subramanian N, Kanwar JR, Athalya PK, Janakiraman N, Khetan V, Kanwar RK, Eluchuri S, Krishnakumar S.  EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.  J. Biomed. Sci.  2015  22:4  PubMed ID: 25576037
9419  Tatsuya Yunoki, Yoshiaki Tabuchi, Atsushi Hayashi, Takashi Kondo  BAG3 Protects Against Hyperthermic Stress by Modulating NF-κB and ERK Activities in Human Retinoblastoma Cells  Graefes Arch Clin Exp Ophthalmol  2015  253(3):399-407  PubMed ID: 25471019
13761  Venkatesan N, Krishnakumar S, Deepa PR, Deepa M, Khetan V, Reddy MA.  Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells  Mol Vis  2012  18:2420-37  PubMed ID: 23077401
8007  Endo S, Yamato K, Hirai S, Moriwaki T, Fukuda K, Suzuki H, Abei M, Nakagawa I, Hyodo I.  Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells.  Cancer Sci.  2011  102:605-13  PubMed ID: 21205074
8620  Mikami-Terao Y, Akiyama M, Yuza Y, Yanagisawa T, Yamada O, Kawano T, Agawa M, Ida H, Yamada H.  Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.  Exp. Eye Res.  2009  89:200-8  PubMed ID: 19328784

Back Back Return Top Page